Justin T. Ernst

2.0k citations

20 papers · 1.3k indexed · h-index 13

Molecular Biology top 10%
Organic Chemistry top 5%
Oncology
Radiology, Nuclear Medicine and Imaging top 10%
Computational Theory and Mathematics top 5%

Co-authors: Andrew D. Hamilton Brendan P. Orner Hyung Soon Park Hang Yin Olaf Kutzki Jorge Becerril Asim K. Debnath Shibo Jiang
Topics: Chemical Synthesis and Analysis (4 papers)HIV Research and Treatment (4 papers)Click Chemistry and Applications (3 papers)
Cited by: Organic Chemistry Virology Molecular Biology
Journals: Journal of the American Chemical Society Angewandte Chemie International Edition Cancer Research
Partner nations: United States

In The Last Decade

Justin T. Ernst

20 papers receiving 1.3k citations

Peers

Countries citing papers authored by Justin T. Ernst

Since Specialization

Citations

This map shows the geographic impact of Justin T. Ernst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin T. Ernst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin T. Ernst more than expected).

Fields of papers citing papers by Justin T. Ernst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin T. Ernst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin T. Ernst. The network helps show where Justin T. Ernst may publish in the future.

Co-authorship network of co-authors of Justin T. Ernst

This figure shows the co-authorship network connecting the top 25 collaborators of Justin T. Ernst. A scholar is included among the top collaborators of Justin T. Ernst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin T. Ernst. Justin T. Ernst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	1-Aminomethyl SAR in a novel series of flavagline-inspired eIF4A inhibitors: Effects of amine substitution on cell potency and in vitro PK properties 2021 ·Bioorganic & Medicinal Chemistry Letters ·Christian Nilewski,(unknown),Garrick K. Packard,Alan X. Xiang,Paul A. Sprengeler,Boreth Eam,Sarah Fish,Peggy A. Thompson,Christopher J. Wegerski,(unknown),(unknown),Samuel Sperry,Justin T. Ernst,Siegfried Reich	2
2	Strategic Diastereoselective C1 Functionalization in the Aza-Rocaglamide Scaffold toward Natural Product-Inspired eIF4A Inhibitors 2020 ·Organic Letters ·Christian Nilewski,(unknown),Alan X. Xiang,Garrick K. Packard,Paul A. Sprengeler,Boreth Eam,Sarah Fish,Peggy A. Thompson,Christopher J. Wegerski,Justin T. Ernst,Siegfried Reich	9
3	Abstract PR11: eFT508: An oral, potent and highly selective inhibitor of MNK1 and MNK2, promotes anti-tumor immunity as a monotherapy and in combination with immune checkpoint blockade 2017 ·Cancer Research ·Kevin R. Webster,Vikas Goel,Jocelyn Staunton,(unknown),Gregory S. Parker,Craig R. Stumpf,(unknown),Gary G. Chiang,Christopher J. Wegerski,Samuel Sperry,Joan Chen,Vera Huang,Peggy A. Thompson,Chinh Tran,Justin T. Ernst,Stephen E. Webber,Paul A. Sprengeler,Siegfried Reich	3
4	Abstract 596: eFT508, a potent and highly selective inhibitor of MNK1/2 regulates immune checkpoint and cytokine expression promoting anti-tumor immunity 2017 ·Cancer Research ·Kevin R. Webster,Vikas Goel,Jocelyn Staunton,Craig R. Stumpf,Rajesh Sharma,(unknown),Gregory S. Parker,(unknown),Gary G. Chiang,Christopher J. Wegerski,Samuel Sperry,Vera Huang,Joan W. Chen,Peggy A. Thompson,Chinh Tran,Justin T. Ernst,Paul A. Sprengeler,Siegfried Reich	3
5	Discovery of novel oxazepine and diazepine carboxamides as two new classes of heat shock protein 90 inhibitors 2015 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Justin T. Ernst,Jeremy J. Clemens,Paul Krenitsky,Michael Liu,Beth A. Fleck,(unknown),Harmon Zuccola,Dean Stamos	8
6	Identification of Novel HSP90α/β Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration of Potential Utility in Treating CNS Disorders such as Huntington’s Disease 2014 ·Journal of Medicinal Chemistry ·Justin T. Ernst,(unknown),Michael C. Liu,Samuel Sperry,Harmon Zuccola,(unknown),Beth A. Fleck,William J. Kargo,(unknown),(unknown),(unknown),Weichao Chen,Phillip W. Snyder,(unknown),Azin Nezami,James M. Reynolds,Khisal A. Alvi,Lance Goulet,Dean Stamos	55
7	Correlation between chemotype-dependent binding conformations of HSP90α/β and isoform selectivity—Implications for the structure-based design of HSP90α/β selective inhibitors for treating neurodegenerative diseases 2013 ·Bioorganic & Medicinal Chemistry Letters ·Justin T. Ernst,Michael Liu,Harmon Zuccola,Thomas A. Neubert,Kevin Beaumont,(unknown),(unknown),Bryan W. Vought,Dean Stamos	50
8	Diastereoselective One-Pot Knoevenagel Condensation/Corey–Chaykovsky Cyclopropanation 2012 ·The Journal of Organic Chemistry ·Jeremy J. Clemens,Juliana L. Asgian,Brett B. Busch,(unknown),Justin T. Ernst,(unknown),Paul Krenitsky,(unknown),Edwin J. Schweiger,Andreas Termin,Dean Stamos	12
9	KR-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinase 2010 ·European Journal of Pharmacology ·Antonio Montalbán,(unknown),(unknown),(unknown),Russell Dahl,(unknown),(unknown),(unknown),Justin T. Ernst,Andrew R. Gibbs,(unknown),Linda Kessler,Jan O. Lundström,Stephen E. Miller,Hiroshi Nakanishi,Edward Roberts,Eddine Saiah,(unknown),Zhijun Wang,Christopher J. Larson	9
10	The design and synthesis of novel α-ketoamide-based p38 MAP kinase inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Antonio Montalbán,(unknown),(unknown),(unknown),Russell Dahl,(unknown),(unknown),(unknown),Justin T. Ernst,Andrew R. Gibbs,(unknown),Linda Kessler,Jan O. Lundström,Stephen E. Miller,Hiroshi Nakanishi,Edward Roberts,Eddine Saiah,(unknown),Zhijun Wang,Christopher J. Larson	18
11	Anti-HIV-1 entry optimization of novel imidazopiperidine-tropane CCR5 antagonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·Justin T. Ernst,Russell Dahl,(unknown),(unknown),Ján Urban,Stephen G. Miller,Jan O. Lundström	15
12	Terphenyl-Based Bak BH3 α-Helical Proteomimetics as Low-Molecular-Weight Antagonists of Bcl-x _L 2005 ·Journal of the American Chemical Society ·Hang Yin,(unknown),(unknown),Olaf Kutzki,Hyung Soon Park,Brendan P. Orner,Justin T. Ernst,Hong‐Gang Wang,Saı̈d M. Sebti,Andrew D. Hamilton	166
13	Protein recognition using synthetic surface-targeted agents 2004 ·Molecular Diversity ·Rishi K. Jain,Justin T. Ernst,Olaf Kutzki,Hyung Soon Park,Andrew D. Hamilton	23
14	Design and Application of an α‐Helix‐Mimetic Scaffold Based on an Oligoamide‐Foldamer Strategy: Antagonism of the Bak BH3/Bcl‐xL Complex 2003 ·Angewandte Chemie International Edition ·Justin T. Ernst,Jorge Becerril,Hyung Soon Park,Hang Yin,Andrew D. Hamilton	232
15	Design and Application of an α‐Helix‐Mimetic Scaffold Based on an Oligoamide‐Foldamer Strategy: Antagonism of the Bak BH3/Bcl‐xL Complex 2003 ·Angewandte Chemie ·Justin T. Ernst,Jorge Becerril,Hyung Soon Park,Hang Yin,Andrew D. Hamilton	57
16	XTT Formazan Widely Used to Detect Cell Viability Inhibits HIV Type 1 Infection in Vitro by Targeting gp41 2002 ·AIDS Research and Human Retroviruses ·Qian Zhao,Justin T. Ernst,Andrew D. Hamilton,Asim K. Debnath,Shibo Jiang	39
17	Design of a Protein Surface Antagonist Based on α-Helix Mimicry: Inhibition of gp41 Assembly and Viral Fusion We thank the National Institutes of Health for support of this work and the Deutsche Forschungsgemeinschaft (DFG) for a research fellowship to O.K. 2002 ·Angewandte Chemie International Edition ·Justin T. Ernst,Olaf Kutzki,Asim K. Debnath,Shibo Jiang,Hong Lü,Andrew D. Hamilton	140
18	Design of a Protein Surface Antagonist Based onα-Helix Mimicry: Inhibition of gp41 Assembly and Viral Fusion 2002 ·Angewandte Chemie ·Justin T. Ernst,Olaf Kutzki,Asim K. Debnath,Shibo Jiang,Hong Lü,Andrew D. Hamilton	23
19	Development of a Potent Bcl-x_LAntagonist Based on α-Helix Mimicry 2002 ·Journal of the American Chemical Society ·Olaf Kutzki,Hyung Soon Park,Justin T. Ernst,Brendan P. Orner,Hang Yin,Andrew D. Hamilton	210
20	Toward Proteomimetics: Terphenyl Derivatives as Structural and Functional Mimics of Extended Regions of an α-Helix 2001 ·Journal of the American Chemical Society ·Brendan P. Orner,Justin T. Ernst,Andrew D. Hamilton	267

About Justin T. Ernst

Justin T. Ernst is a scholar working on Virology, Molecular Biology and Organic Chemistry, having authored 20 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (4 papers), HIV Research and Treatment (4 papers) and Click Chemistry and Applications (3 papers). The work is most often cited by research in Organic Chemistry (636 citations), Virology (97 citations) and Molecular Biology (1.1k citations). Justin T. Ernst has collaborated with scholars based in United States. Frequent co-authors include Andrew D. Hamilton, Brendan P. Orner, Hyung Soon Park, Hang Yin, Olaf Kutzki, Jorge Becerril, Asim K. Debnath, Shibo Jiang, Hong Lü and Saı̈d M. Sebti. Their work appears in journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact